다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Eledon Pharmaceuticals Inc (ELDN)
Eledon Pharmaceuticals Inc (ELDN) 뉴스

ELDN

Eledon Pharmaceuticals (ELDN)

Eledon Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ELDN

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/15	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/06/15	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/06/15	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/06/15	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/06/07	05:01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/06/06	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/06/04	05:01	GlobeNewswire Inc.	Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/31	05:25	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/31	05:05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/25	05:02	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/15	20:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/14	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/09	20:30	GlobeNewswire Inc.	Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/09	20:00	GlobeNewswire Inc.	Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/07	20:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/07	20:05	GlobeNewswire Inc.	Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/07	20:00	GlobeNewswire Inc.	Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/03/29	05:01	GlobeNewswire Inc.	Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/03/26	05:56	GlobeNewswire Inc.	Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/03/21	23:31	GlobeNewswire Inc.	Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/02/15	05:35	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/02/15	05:01	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/02/14	09:01	GlobeNewswire Inc.	Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/01/05	06:40	GlobeNewswire Inc.	Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/12/05	08:00	GlobeNewswire Inc.	Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/11/30	06:05	GlobeNewswire Inc.	Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/11/10	07:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/11/10	06:01	GlobeNewswire Inc.	Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/11/09	06:05	GlobeNewswire Inc.	Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/11/03	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELDN	Eledon Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:ELDN

1 2 3 4 5 6 다음 >>

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관